SENSEX NIFTY

Herceptin

Apr 26, 2016 at 20:00 | Source: PTI
Biotechnology firm Biocon today said its product portfolio will not be affected by an order of the Delhi High Court that prevented the company from calling its breast cancer medicine Trastuzumab as a biosimilar of Roche's Herceptin.
Oct 12, 2015 at 19:41 | Source: PTI
These targeted medicines represent a completely new way to treat HER2-positive metastatic breast cancer, with which the company aims to help women in India live as long and as well as possible, he added.
Feb 07, 2014 at 22:27 | Source: CNBC-TV18
The Delhi High Court (HC) has thrown a wrench into plans of Biocon and Mylan to market a breast cancer drug that goes by the scientific name Trastuzumab.
Feb 04, 2014 at 09:59 | Source: PTI
The company's subsidiary Mylan Pharmaceuticals Pvt Ltd has launched the world's first trastuzumab biosimilar, which will be marketed by Mylan under the brand name Hertraz Herceptin, a company statement said.
Jan 18, 2014 at 16:21 | Source: Reuters
Bangalore-based Biocon jointly developed biosimilar trastuzumab, which received the Indian drug regulator's marketing approval in November, with US-based Mylan Inc.
Oct 01, 2012 at 13:06 | Source: Reuters
ROCHE-HERCEPTIN-CANCER-TRIAL:Cancer trials show 1 year on Roche's Herceptin is best
Apr 02, 2012 at 09:46 | Source: Reuters
In a nondescript suburb south of London, tucked away behind a big hospital, Paul Workman and fellow scientists are celebrating victory in the "World Cup" of cancer drug research for their work in discovering a stream of new medicines.
Mar 23, 2012 at 11:56 | Source: Reuters
Roche Holding AG will launch two locally branded cancer drugs in India at "significantly lower" prices by the end of this year or early next year, a Roche spokesman said on Friday.
Oct 28, 2009 at 17:10 | Source: CNBC-TV18
Dr YK Hamied, CMD, Cipla, expects export growth mainly from anti-AIDS drugs. "We are targeting exports of over Rs 3,000 crore for FY10 and have already reached Rs 1,440 crore in the first six months."
Aug 09, 2007 at 19:12
It is raining product patents for Swiss drug maker Roche. Roche has received four product patents for its global drug brands while fellow Swiss pharma firm Novartis is still struggling with the Indian patent laws reports CNBC-TV18.
Messages on Herceptin »

dhruvfun

New Member

3 Followers

Biocon  

i can`t believe how people are not able to understand what biocon is !! biocon is a world class biopharma firm, that has world class talent pool of scientists!! its trastuzumab biosimilar is showing much better results than herceptin which generates 40,000 crores alone in revenue for roche!! it

10.07 AM Jan 5th

unseenvalue

Gold Member

429 Followers

Panacea Biotec  

Biosimilar Herceptin 3. Caveat: Debt is relatively high and am not too sure on the CDR status 4. Please share your views as well Disclosure: recent investment so may be biased

11.56 PM Nov 1st 2016

savera_patn
a

Platinum Member

40 Followers

Biocon  

gone from having zero approved biosimilars to three, and it seems we are only at the beginning for this burgeoning industry, with key patents for such biologic blockbusters as AbbVie’s Humira and Roche’s Herceptin set to expire.

10.55 PM Sep 14th 2016

Willwin

Platinum Member

1088 Followers

Biocon  

Mylan`s marketing application for Herceptin biosimilar accepted for review in Europe Aug 25 2016, 11:05 ET | About: Mylan Inc (MYL) | By: Douglas W. House, SA News Editor [Contact this editor with comments or a news tip] The European Medicines Agency (EMA) accepts for review the Marketing

9.18 PM Aug 25th 2016

Wire News

Platinum Member

694 Followers

News Now  

ROCHE-HERCEPTIN-CANCER-TRIAL:Cancer trials show 1 year on Roche's Herceptin is best

1.06 PM Oct 1st 2012

ramanujam11

Gold Member

24 Followers

Biocon  

Results were good.Unexpectedly better than I anticipated. Biosimilar Trastuzumab (Herceptin, Mylan alliance) commences Phase III trials in India. This seems to be a new drug which I did not know this either. It appears,they have lot more valuable molecule which are yet to be valued. KMS is silent

2.03 PM Apr 27th 2012

arcadiastoc
ks82

Platinum Member

914 Followers

Other Market Topics  

of its Herceptin and Mabthera cancer drugs, Daniel Grotzky said in a phone interview from the company headquarters in Basel, Switzerland."The scope is to enable access for a large majority of patients who currently pay out of pocket as well as to partner with the government to enable increased access

1.48 PM Mar 23rd 2012

Web Messenger

Platinum Member

369232 Followers

News Now  

Source:Forbes - Image via Wikipedia   Switzerland-based pharmaceutical giant Roche (RHHBY) is busy preparing to  defend one of its three major cancer drugs, Herceptin – whose patent expires in 2014 — from the onslaught of generic drugs. One of Roche’s major oncology drugs, Herceptin is a t

12.36 PM Mar 16th 2012

Web Messenger

Platinum Member

369232 Followers

News Now  

Herceptin image via Wikipedia In a sign of the increasing hunger among drug giants to get in on the potentially lucrative market for copycats of expensive biotechnology drug, Amgen, the largest standalone biotechnology company, and generic firm Watson Pharmaceuticals will collaborate on developing

10.33 AM Dec 20th 2011

stocktin

Platinum Member

64 Followers

Biocon  

is obviously some time away but by the time that happens biocon wd have doubled or maybe trebled its business by penetrating more & more emerging markets with their insulins. Secondly since herceptin is also undergoing phase iii multicentric trials in india i beleive mabs shall also be lunched in india

6.01 PM Nov 3rd 2012

News across the web »
Feb 06, 2015 at 00:45 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.